Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio                       Top pulmonology news from July: FDA updates, antibiotics in cystic fibrosis, treatment of COPD exacerbations - Healio       Posted:  02 Aug 2019 06:01 AM PDT     Healio Pulmonology  has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology  in July.   See below for links to a study on reducing antibiotic use for COPD exacerbations, the outcome of an FDA advisory committee meeting on nintedanib for a rare form of interstitial lung disease, updates on treatment of respiratory infections in patients with cystic fibrosis and more.   C-reactive protein testing safely reduces antibiotic use for COPD exacerbations   The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a...
 
Comments
Post a Comment